iCAD (NASDAQ:ICAD - Get Free Report) posted its earnings results on Wednesday. The technology company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.02, Zacks reports. iCAD had a negative return on equity of 15.65% and a negative net margin of 17.81%. The business had revenue of $5.41 million during the quarter, compared to the consensus estimate of $4.72 million.
iCAD Stock Performance
iCAD stock traded up $0.14 during mid-day trading on Friday, reaching $2.23. 274,829 shares of the company were exchanged, compared to its average volume of 252,369. iCAD has a twelve month low of $1.18 and a twelve month high of $3.78. The firm's 50-day simple moving average is $2.65 and its two-hundred day simple moving average is $2.06. The firm has a market cap of $59.18 million, a PE ratio of -17.15 and a beta of 1.95.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded iCAD from a "hold" rating to a "sell" rating in a report on Tuesday, March 18th.
Check Out Our Latest Stock Report on iCAD
About iCAD
(
Get Free Report)
iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.
See Also
Before you consider iCAD, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iCAD wasn't on the list.
While iCAD currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
